Comparison of vacuum-assisted excision (VAE) and breast lesion excision system (BLES) in the treatment of intraductal papillomas
Autor: | Michaela Björnström, Katja Hukkinen, Tuomo J. Meretoja, Marjut Leidenius, Laura Niinikoski |
---|---|
Přispěvatelé: | HUS Medical Imaging Center, Department of Diagnostics and Therapeutics, HUS Diagnostic Center, HUS Comprehensive Cancer Center, Department of Oncology, Department of Surgery, II kirurgian klinikka |
Jazyk: | angličtina |
Rok vydání: | 2022 |
Předmět: |
Adult
Male medicine.medical_specialty Breast lesion excision system (BLES) Vacuum Vacuum assisted Breast lesion 3122 Cancers Breast Neoplasms Mastectomy Segmental 030218 nuclear medicine & medical imaging Papilloma Intraductal Lesion Vacuum-assisted excision (VAE) 03 medical and health sciences 0302 clinical medicine REMOVAL PATIENT PATHWAY Intraductal papilloma Atypia Humans Medicine Aged Aged 80 and over RISK business.industry Ultrasound Surgical excision Retrospective cohort study General Medicine Middle Aged High-risk lesion medicine.disease University hospital 3126 Surgery anesthesiology intensive care radiology Tumor Burden 3. Good health Surgery Computer-Assisted Oncology 030220 oncology & carcinogenesis BIOPSY Female Surgery Radiology medicine.symptom business |
Popis: | Purpose: This study aims to compare the feasibility of VAE and BLES in the treatment of intraductal papillomas. Material and methods: Patients with a suspected intraductal papilloma who underwent a BLES or a VAE procedure were included in this retrospective study. The BLES procedures were performed between November 2011 and June 2016 and the VAE procedures between May 2018 and September 2020 at the Department of Radiology of Helsinki University Hospital (HUH). The procedures were performed with an intent of complete removal of the lesions. Results: In total, 72 patients underwent 78 BLES procedures and 95 patients underwent 99 VAE procedures. Altogether 52 (60%) papillomas with or without atypia were completely removed with VAE, whereas 24 (46%) were completely removed with BLES, p = 0.115. The median radiological size of the high-risk lesions completely removed with BLES was 6 mm (4-12 mm), whereas with VAE it was 8 mm (3-22 mm), p = 0.016. Surgery was omitted in 90 (94.7%) non-malignant breast lesions treated with VAE and in 66 (90.4%) treated with BLES, p = 0.368. Conclusion: Both VAE and BLES were feasible in the treatment of intraductal papillomas. In most non-malignant lesions surgery was avoided, but VAE was feasible in larger lesions than BLES. However, follow-up ultrasound was needed more often after VAE. The histopathologic assessment is more reliable after BLES, as the lesion is removed as a single sample. (C) 2021 The Authors. Published by Elsevier Ltd. |
Databáze: | OpenAIRE |
Externí odkaz: |